The World Health Organization‘s vaccine safety panel said on Friday that available data from ‘s COVID-19 shot do not point to any overall increase in clotting conditions but it would continue to monitor for any adverse effects. “The AstraZeneca COVID-19 vaccine (including Covishield) continues to have a positive benefit-risk profile, with tremendous potential to prevent … Read more
March 15, 2021 — A number of nations have paused using the AstraZeneca COVID-19 vaccine because of reports the vaccine might be linked to blood clots. Germany, France, Italy, and Spain have become the latest countries to suspend using the vaccine, joining Ireland, Denmark, Thailand, the Netherlands, Norway, Iceland, Congo, and Bulgaria. AstraZeneca issued a … Read more
SII will be manufacturing around 60 million doses a month from the two plants in Pune. Serum Institute of India (SII), the world’s largest vaccine manufacturer, will be ready with 300 million doses of the Covishield Oxford-AstraZeneca Covid-19 vaccine by July 2021. Adar Poonawalla, COO, SII, said they have a stockpile of 40-50 million doses … Read more
A volunteer is administered the coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. (AP/File photo) Oxford COVID-19 vaccine: The interim results of the Oxford COVID-19 vaccine trials have found that in 70% of cases the vaccine protects against Coronavirus, as per details published in The Lancet on Tuesday. Where two full doses were … Read more
Scientists and technical experts who understand the disclosure and examination process say, if the regulator was informed in time and the investigation is still on then what has guided the decisions on the continuance of the trials. By E Kumar Sharma, In the journey of a vaccine development, the phase 3 trials cover the … Read more
One month has passed since China officially launched the urgent use of COVID-19 vaccines on July 22, while the vaccines were going through clinical trials, Zheng said. (Representational image) China has authorised emergency usage of COVID-19 vaccines developed by some select domestic companies, a Chinese health official has said. An emergency use authorisation, which is … Read more